Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04836936 · ClinicalTrials.gov registry record · NA
Auriculotherapy in the Treatment of Pre-Operative Anxiety
A NA study of Anxiety Preoperative, sponsored by Jacques E. Chelly.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04836936: Recruiting NA study of Anxiety Preoperative, sponsored by Jacques E. Chelly.
NCT04836936 is a NA study of Anxiety Preoperative that is actively recruiting participants, run by Jacques E. Chelly. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04836936, a NA study of Anxiety Preoperative, is actively recruiting participants, sponsored by Jacques E. Chelly.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to use the validated PROMIS Emotional Distress - Anxiety - Short Form 8a and PROMIS Emotional Distress-Depression-Short Form pre-and post-intervention to establish a superior correlation between the auriculotherapy treatment and the reduction of perioperative anxiety. Subject population will include those having a partial or total nephrectomy for cancer. Drawing the role that auriculotherapy may play in reducing perioperative anxiety related requirement after surgery may also help in reducing the risk of opioid use disorders (OUD) since anxiety has been found to be a major risk factor for OUD in surgical patients. Therefore, this trial will also examine the effect of the auriculotherapy intervention in reducing opioid requirement after surgery.
Primary Outcome
Demonstrate how auriculotherapy using the cryopuncture device changes participant's total opioid consumption following nephrectomy surgery.
Conditions Studied
Interventions
- DEVICE Auriculotherapy cryopuncture device without nitrogen gas
- DEVICE Auriculotherapy cryopuncture device with nitrogen gas
Study Locations (1)
Pennsylvania
- UPMC Shadyside Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-04-13 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What NCT04836936 shows while recruiting
NCT04836936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Anxiety Preoperative appearing as the primary indexed condition, and to 2 interventions - of which Auriculotherapy cryopuncture device without nitrogen gas is the first listed.
NCT04836936 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04836936 about?
NCT04836936 is a clinical study titled "Auriculotherapy in the Treatment of Pre-Operative Anxiety". The goal of this clinical trial is to use the validated PROMIS Emotional Distress - Anxiety - Short Form 8a and PROMIS Emotional Distress-Depression-Short Form pre-and post-intervention to establish a superior correlation between the auriculotherapy treatment and the reduction of perioperative anxie...
What is the current status of trial NCT04836936?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-04-13. Estimated completion is 2026-03-30.
What conditions does trial NCT04836936 study?
This clinical trial studies the following conditions: Anxiety Preoperative.
What interventions are being tested in trial NCT04836936?
The interventions under investigation include: Auriculotherapy cryopuncture device without nitrogen gas (DEVICE), Auriculotherapy cryopuncture device with nitrogen gas (DEVICE).
Who is sponsoring clinical trial NCT04836936?
This trial is sponsored by Jacques E. Chelly, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04836936 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Preoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04836936's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI